Skip to main content

Table 2 Demographic and clinical characteristics of the Parkinson’s disease patient groups n = 96

From: Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)

Patient groups PD-N
(n = 51)
PD-MCI (n = 30) PDD
(n = 15)
Analysis Significant post-hoc differences (N-K or T2)
Age 68.23 ± 7.60 69.5 ± 6.86 72.73 ± 4.85 F2,93 = 2.39, p = .09  
Female: Male 16/35 9/21 3/12 X 2 = .74, p = .69  
Education (yrs) 13.14 ± 3.03 12.56 ± 1.99 12.26 ± 2.49 F2,93 = .82, p = .44  
GDS 1.45 ± 2.88 0.73 ± 1.79 2.13 ± 3.14 F2,93 = 1.29, p = .28  
H&Y 2.10 ± 0.52 2.30 ± 0.75 2.33 ± 0.59 F2, 90 = 1.48, p = .23  
NPI 3.14 ± 5.21 4.37 ± 4.62 8.13 ± 9.26 F2, 89 = 4.83, p < .05 PD-N v PDD, p < .05
ADL-IS .51 ± 0.51 .78 ± 0.47 2.04 ± 0.54 F2,91 = 55.35, p < .0001 PD-N v PDD, p < .001
PD-MCI v PDD, p < .001
Disease Duration (yrs) 7.54 ± 4.00 9.10 ± 4.44 11.63 ± 6.92 F2, 93 = 4.59, p < .05  
UPDRS-III 25.64 ± 10.80 29.2 ± 13.07 34.83 ± 10.42 F2,92 = 3.84, p < .05 PD-N v PDD, p < .05
  1. Values reported as mean ± standard deviation: GDS-Geriatric Depression Scale; H&Y- Hoehn & Yahr; NPI - Neuropsychiatric Inventory; ADL-IS Activities of Daily Living - International Scale (max = 4.0); UPDRS-III Unified Parkinson’s Disease Rating Scale Part III